- Home
- ELDN vs FINW Comparison
ELDN vs FINW Comparison
Compare ELDN & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- FINW
- Stock Information
- Founded
- ELDN 2004
- FINW 1999
- Country
- ELDN United States
- FINW United States
- Employees
- ELDN N/A
- FINW N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- ELDN Health Care
- FINW Finance
- Exchange
- ELDN Nasdaq
- FINW Nasdaq
- Market Cap
- ELDN 178.4M
- FINW 207.1M
- IPO Year
- ELDN N/A
- FINW 2021
- Fundamental
- Price
- ELDN $3.67
- FINW $15.88
- Analyst Decision
- ELDN Strong Buy
- FINW Buy
- Analyst Count
- ELDN 2
- FINW 4
- Target Price
- ELDN $12.50
- FINW $20.75
- AVG Volume (30 Days)
- ELDN 849.2K
- FINW 74.1K
- Earning Date
- ELDN 08-18-2025
- FINW 07-24-2025
- Dividend Yield
- ELDN N/A
- FINW N/A
- EPS Growth
- ELDN N/A
- FINW N/A
- EPS
- ELDN N/A
- FINW 0.91
- Revenue
- ELDN N/A
- FINW $72,056,000.00
- Revenue This Year
- ELDN N/A
- FINW $37.77
- Revenue Next Year
- ELDN N/A
- FINW $23.58
- P/E Ratio
- ELDN N/A
- FINW $17.25
- Revenue Growth
- ELDN N/A
- FINW 7.66
- 52 Week Low
- ELDN $2.38
- FINW $10.92
- 52 Week High
- ELDN $5.54
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- ELDN 67.56
- FINW 61.41
- Support Level
- ELDN $3.64
- FINW $15.21
- Resistance Level
- ELDN $3.93
- FINW $15.58
- Average True Range (ATR)
- ELDN 0.23
- FINW 0.60
- MACD
- ELDN 0.05
- FINW 0.03
- Stochastic Oscillator
- ELDN 71.91
- FINW 70.34
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.